Laddar...
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
Dimethyl fumarate (DMF) is a first-line-treatment for relapsing-remitting multiple sclerosis (RRMS). The redox master regulator Nrf2, essential for redox balance, is a target of DMF, but its precise therapeutic mechanisms of action remain elusive. Here we show impact of DMF on circulating monocytes...
Sparad:
| I publikationen: | Nat Commun |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626021/ https://ncbi.nlm.nih.gov/pubmed/31300673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-11139-3 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|